China SXT Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2017 Mar2018 Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Revenue & cost
Revenue 0.00B0.01B0.01B0.01B0.00B0.00B0.00B0.00B0.00B
Cost of Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Operating items
Research & Development 0.00B0.00B0.00B
Selling, General & Administrative 0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B
Restructuring Costs 144.35B180.37B0.00B0.00B0.00B0.00B
Other Operating Expenses 0.00B0.00B0.00B-144.35B-180.37B-0.00B0.00B-0.00B0.00B
Operating Expenses 0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.00B0.00B
Operating Income 0.00B0.00B0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.00B
EBIT 0.00B0.00B0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.00B
Non-operating items
Other Non Operating Income 0.00B-0.00B0.00B-0.01B0.00B0.00B0.00B0.00B0.00B
Non Operating Income -0.00B-0.00B0.00B-0.01B0.00B0.00B0.00B-0.00B-0.00B
Net income details
EBT 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Tax Provisions 0.00B0.00B0.00B-0.00B-0.00B0.00B
Profit After Tax 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Income from Continuing Operations 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Consolidated Net Income 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Income towards Parent Company 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Net Income towards Common Stockholders 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Additional items
EPS (Basic) 0.060.06-0.3033.28-3.82-137.92-177.84-28.58-2.32
EPS (Weighted Average and Diluted) 0.060.060.080.03B0.03B-177.84-28.58-2.32
Shares Outstanding (Weighted Average) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Shares Outstanding (Diluted Average) 0.02B0.02B0.00B0.00B
EBITDA 0.00B0.00B0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B
Interest Expenses 0.00B779.000.00B0.00B0.00B0.00B0.00B0.00B0.00B
Tax Rate 25.00%27.04%14.08%0.98%6.55%